Victor Yankiwski
About Victor Yankiwski
Victor Yankiwski is the Global Procurement Category Director for Laboratory Operations at Bristol-Myers Squibb in Summit, NJ, with a background in strategic sourcing and vendor management.
Company
Victor Yankiwski currently works at Bristol-Myers Squibb as the Global Procurement Category Director for Laboratory Operations in Summit, NJ. His role involves overseeing procurement for research laboratory operations, including the acquisition and maintenance of laboratory equipment and regulated materials.
Title
Victor Yankiwski holds the title of Global Procurement Category Director, Laboratory Operations. In this capacity, he is responsible for the procurement life cycle for laboratory supplies, including equipment, maintenance, and consumables, ensuring seamless research operations.
Education and Expertise
Victor Yankiwski earned an MBA in Finance from Rutgers Business School and an MS in Biomedical Sciences from the University of Medicine and Dentistry of New Jersey. He also holds a BS in Biology from Carnegie Mellon University. His educational background equips him with a strong foundation in both business and scientific disciplines, enabling him to navigate complex procurement challenges in the pharmaceutical and laboratory sectors.
Professional Background
Victor Yankiwski’s career spans several notable positions in the pharmaceutical and healthcare industries. He has served in significant roles at Celgene, Novartis, Schering-Plough, and the New York Blood Center. His experience includes positions such as Sourcing Business Partner at Celgene, Associate Director at Novartis, and Manager at Schering-Plough, showcasing his extensive expertise in strategic sourcing and vendor management.
Achievements
Victor Yankiwski has achieved remarkable success in his field. He delivered multi-million-dollar integration related synergies through supply base rationalization and price negotiation, significantly contributing to R&D Procurement's success. He also developed a risk and resiliency dashboard to mitigate COVID-19 related supply risks, and leveraged strategic vendor relationships to ensure consistent supply during the pandemic.